Department of Microbiology, University of Colorado Health Sciences Center, Denver, CO 80262,1 and Departments of Laboratory Medicine and Microbiology, University of Washington School of Medicine, Seattle, WA 98195-72422
*Corresponding author. Phone: (303) 315-0313, Fax: (303) 315-6785, E-mail:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
The chemical reactivity of nitrogen oxides has been exploited in circumstances as varied as clinical medicine, in which these compounds have been administered for over 150 years to treat cardiovascular disorders, or the food industry, in which they have been used as popular preservatives to cure meats. Prout's discovery in 1818 that the urine of febrile patients contains abnormally high nitrite levels pointed to the existence of an endogenous biosynthetic pathway for nitrogen oxides that can be activated as a consequence of inflammation. This finding went largely unnoticed until the 1970s when Tannenbaum reported that the levels of nitrite secreted in human urine exceeded those accounted for by the nitrogen oxides ingested in food (148, 149). The existence of an endogenous nitric oxide (NO) biosynthetic pathway induced in response to inflammatory stimuli was finally demonstrated by Stuehr and Marletta, who showed that lipopolysaccharide (LPS), a major outer membrane structural component of gram-negative bacteria, and gamma interferon (IFN-γ), the prototypical cytokine of T-helper-1-type immune responses, activate murine macrophages to secrete NO (144, 145).
Shortly after NO was found to be secreted by mammalian cells, Hibbs et al. associated NO with phagocyte tumoricidal activity (65). NO-mediated cytotoxicity is not limited to tumors but forms an integral part of the immune response to viruses, bacteria, fungi, and parasites (34, 162). Furthermore, evidence compiled from diverse disciplines in medicine have shown that endogenously produced NO participates in a variety of physiological processes that include neurotransmission and regulation of blood pressure, as well as pathological disorders as varied as inflammation and autoimmunity. This chapter discusses the role that NO and its congeners play on various stages in the pathophysiology of Escherichia coli and Salmonella infections, with special emphasis on the regulatory pathways that lead to high NO synthesis, the role of RNS in host resistance, and the bacterial molecular targets and defense mechanisms that protect enteric bacteria against the nitrosative stress encountered in diverse host anatomical sites.
Although most of the studies analyzing the role of iNOS on the pathogenesis of enteric bacteria have been conducted in macrophages, a multitude of eukaryotic cells have been shown to be capable of expressing iNOS. For example, a growing body of evidence indicates that epithelial cells of the intestinal mucosa can express iNOS in response to gram-negative enteropathogenic bacteria such as E. coli and Salmonella (22, 39, 71, 126). Two pathways have been invoked by which enteric bacteria can activate iNOS transcription in epithelial cells. First, binding of flagella or fimbriae to TLR2 and TLR5 pattern recognition receptors expressed on epithelial cells has been shown to activate IL-1 receptor-associated kinase (IRAK) signaling cascades, nuclear translocation of NF-κB complexes, and iNOS expression (4, 39, 105). In addition to these pathways, Salmonella can stimulate iNOS transcription by directly activating signaling cascades through the enzymatic activity of effectors of the type III secretion system encoded within the Salmonella pathogenicity island 1 (19, 20). Stimulation of iNOS expression by SPI1 effectors may be of biological significance in the epithelium and in macrophages associated with the gastrointestinal mucosa and could play several roles in the pathophysiology of gastroenteritis.
In general, NO can react directly with prosthetic groups containing transition metal centers, with other radicals, or with sulfhydryl groups in the presence of an electron acceptor (Fig. 3). Binding to iron complexes is probably the best characterized direct reaction of NO in biological systems. As discussed below, NO directly interacts with several E. coli and Salmonella hemoproteins and transcriptional regulators containing nonheme iron prosthetic groups. In addition, NO can indirectly mediate important biological actions via RNS generated from its interaction with molecular oxygen and superoxide. The reaction of NO with molecular oxygen follows second- and third-order kinetics for NO. This chemistry requires high NO fluxes that are likely to be sustained in activated macrophages during the course of inflammatory processes. N2O3 generated during the reaction of NO with oxygen is a potent S- and N-nitrosating species that promotes the formation of S-nitrosothiols and N-nitrosamines and, in addition, can act as an oxidant. Another indirect reaction of NO is via peroxynitrite, which arises from the interaction of NO and superoxide anion. Peroxynitrite is a strong oxidant capable of nitrating a variety of substrates including tyrosine residues. The presence of nitrotyrosine in infected macrophages and tissues has suggested that peroxynitrite might play a role in Salmonella pathogenesis. However, formation of nitrotyrosine is not unequivocal proof of peroxynitrite synthesis, since this modification can arise by the enzymatic action of peroxidases on nitrite, hydrogen peroxide, and tyrosine (41) or by nitrite alone at acid pH (70). This chemistry is most likely to occur in the setting of acute inflammation. In fact, nitrotyrosine in Salmonella-infected tissues has been correlated with the expression of both myeloperoxidase and iNOS (2).
The targets of RNS are numerous. RNS can facilitate oxidative modifications including lipid peroxidation, hydroxylation, and DNA base and protein oxidation. In addition, RNS can inflict nitrosative stress through the nitrosation of amines and sulfhydryls. These modifications can result in nucleic acid deamination, enzyme inhibition (e.g., DNA ligase), zinc finger disassembly, and Fe-S cluster degradation.
Despite having an unpaired electron in the outer orbital, NO has the potential to freely diffuse across lipid membranes. In addition, low-molecular-weight S-nitrosothiols can be actively transported by enteric bacteria across the cell wall into the cytosol. The dipeptide permease encoded in the dpp operon has been shown to facilitate the cytotoxicity of GSNO for Salmonella ( 30). A γ-glutamyl transpeptidase cleaves the glutamic acid of GSNO to generate S-nitrosocysteinylglycine, which is transported by the Dpp permease into the Salmonella cytosol. S-Nitrosocysteinylglycine can then liberate NO homolytically or donate NO+ equivalents in transnitrosation reactions. Inside the cell, NO can modify a number of targets containing Fe-S clusters, heme groups, zinc fingers, or other radical species.
Fe-S Clusters.
Dehydratases, including aconitase, fumarase, glyceraldehyde-3-phosphate dehydrogenase, and 6-phosphogluconate dehydratase, contain Fe-S prosthetic groups that are susceptible to RNS (50, 51, 59, 75, 170). Whether the E. coli 4Fe-4S protein aconitase, an enzyme that converts citrate to isocitrate in the Krebs cycle, can be directly or indirectly modified by NO has been the subject of intense debate. Three iron molecules in the cluster are bound by cysteine residues, while the fourth ferrous atom is accessible to the substrate. There appears to be a consensus that oxidants such as peroxynitrite or superoxide react with the apical iron in the ferrous state, inactivating the enzyme irreversibly (possibly by inducing formation of disulfide bonds) (59, 75). However, whether NO can directly react with the solvent-exposed iron in the 4Fe-4S cluster is controversial (51, 59). Electron paramagnetic resonance spectroscopy has revealed the generation of dinitrosyl-iron complexes in NO-treated Fnr (4Fe-4S) and SoxR (2Fe-2S) transcriptional regulators (26, 36). These observations are consistent with the view that NO by itself is capable of modifying Fe-S clusters.
Heme-Containing Metabolic Enzymes.
Enterobacteria express several hemoproteins that are susceptible to NO inhibition. Cytochrome bo contains a low-spin heme b coordinated by two histidines, a high-spin heme o ligated by a single histidine, and a CuB atom coordinated by three histidines. Although cytochrome bo bears two heme groups, the CuB site can be the target of up to two nitrosylations (14). In addition to cytochrome bo, E. coli contains a bd-type ubiquinol oxidase that is expressed in the respiratory chain under low-oxygen tension (58). In this case, NO inhibits the two heme groups of the db binuclear center (63, 67, 170). E. coli respiratory cytochromes can be protected by induction of the Hmp flavohemoglobin, which metabolizes NO to nitrate (140). In addition to binding cytochromes of the aerobic respiratory chain, NO has been shown to inhibit the E. coli hemoprotein catalase (11) and to bind to the reduced iron of E. coli and Salmonella Hmp flavohemoglobins (49, 60).
Zinc Fingers.
Zinc-binding motifs, also known as zinc fingers, mediate a wide variety of protein-DNA or protein-protein interactions. Although zinc-binding motifs are highly pleomorphic, free thiols are generally involved in coordination of the metal center. Recent observations have revealed that S-nitrosylation of sulfhydryls coordinating the zinc finger releases the metal, reversibly inhibiting protein function (82, 83). In Salmonella, the bacteriostasis and cell filamentation seen in response to GSNO coincides with intracellular zinc mobilization (132). Zinc fingers in the metalloproteins PriA, DnaG, and DnaJ, which are involved in DNA replication and reinitiation of collapsed replication forks, might be targets of S-nitrosylation in these experiments. In support of this hypothesis, the SOS response, which is elicited in the absence of functional PriA (115), is induced in GSNO-treated Salmonella in association with zinc mobilization, bacteriostasis, and cell filamentation (132).
Organic Radicals.
As described above for superoxide anion, molecules containing unpaired electrons are extraordinarily susceptible to attack by NO. Ribonucleotide reductase is one such target. By catalyzing the reduction of ribonucleotides to deoxyribonucleotides, ribonucleotide reductases play a critical role in DNA synthesis. In E. coli, as is the case for other class I ribonucleotide reductases, the active site of the enzyme contains a tyrosyl radical that is easily quenched by NO (57, 84).
Methionines.
Methionines can be oxidized to the sulfoxide Met-O form by ROS and RNS. This lesion can be lethal if left unrepaired as suggested by the RNS hypersusceptibility of E. coli lacking the methionine sulfoxide reductase MsrA (139). The reversibility of this oxidative lesion has prompted the idea that surface-exposed methionines may serve as repairable sinks that protect intracellular targets from oxidative damage (85). The cytotoxicity of NO donors against msrA mutant E. coli is only manifested under aerobic conditions, suggesting that RNS generated during the reaction of NO and oxygen mediate the oxidation of methionine. Peroxynitrite is a likely candidate since it has been shown to oxidize methionines (122, 165), including those present in the E. coli chaparone GroEL (77).
Numerous vital bacterial molecules can be targeted by NO. It is therefore not surprising that enteropathogenic bacteria are armed with a number of sensors to coordinate the protective response to nitrosative stress, along with an assortment of antinitrosative defenses that detoxify, repair, or avoid the deleterious effects of RNS encountered within the host.
Metal cofactors and free sulfhydryl groups have been coopted by transcriptional activators as sensors for nitrosative stress. The transcriptional activator SoxR was the first NO sensor to be identified in enteric bacteria (114). Oxidized SoxR has high affinity for the soxS promoter, whereas reduced SoxR binds to this promoter but it does not recruit the σ70 RNA polymerase (35). Nitrosylation of the iron in the 2Fe-2S cluster activates SoxR (36). Activation of the soxRS operon by NO induces the expression of glucose-6-phosphate dehydrogenase, which generates NADPH-reducing equivalents for antioxidant enzymes, as well as ferrodoxin:NADPH oxidoreductase, involved in repair of oxidized Fe-S clusters (89). Nitrosative stress is also a signal that activates OxyR, a transcriptional regulator that coordinates the expression of E. coli and Salmonella antioxidant defenses against hydrogen peroxide. OxyR DNA binding is stimulated by the oxidation of a redox-active cysteine residue to sulfenic acid, which may subsequently form a disulfide bond with a vicinial cysteine residue (172). Alternatively, OxyR can directly sense NO through S-nitrosylation of one of this cysteine (62). The induction of gor by S-nitroso-OxyR maintains a pool of reduced glutathione that can help to detoxify RNS. Recent data, however, suggest that SoxR and OxyR are not primary regulators of the E. coli nitrosative protective response (106). It is possible that in the normally reduced environment of the cytoplasm (62), NO does not nitrosylate either the 2Fe-2S cluster of SoxR or the redox active cysteines of OxyR. However, depletion of glutathione in the oxidative environment of phagocytes might conceivably enable NO sensing by these regulators (113).
The iron prosthetic group of the transcriptional factor Fur (ferric uptake regulation), which is involved in maintaining iron homeostasis, has also been coopted as an NO sensor (28). Formation of a nitrosyl-iron-Fur complex derepresses transcription of Fur-regulated genes in Salmonella and E. coli (27, 28). Similarly, nitrosylation of the 4Fe-4S prosthetic group of Fnr allows expression of the E. coli hmp gene (26). More recently, the NO reductase regulator NorR has also been shown to sense various RNS (106). Although the mechanism by which NorR senses NO is not known, it is likely to involve one or more cysteine residues (105). NorR activates the expression of the NO-consuming flavorubredoxin and flavorubredoxin reductase system (50). It will be interesting to determine the contribution of NorR, which is preferentially expressed under low oxygen tension, to the virulence of E. coli and Salmonella in the microaerophilic or anaerobic environments of the phagosome, granuloma, and intestinal mucosa. There appear to be additional NO sensors, since hmp is expressed normally in E. coli lacking metR, fur, norR, soxR, or oxyR (106). The global regulatory protein ArcA is an additional potential NO sensor (87).
The field of oxygen radical biology followed in the wake of the discovery of the superoxide-consuming activity of superoxide dismutase. Therefore, the long interval between the discovery of endogenous NO synthesis and the first identification of RNS-metabolizing enzymes is somewhat surprising. A variety of enzymes with different catalytic sites and various prosthetic groups are now known to detoxify NO and other RNS.
Detoxification of NO.
NO is an intermediate of the nitrogen cycle, in which nitrate/nitrite are reduced to molecular N2. In denitrifying bacteria, NO reductases contain a heme b3-FeB binuclear center that converts NO to N2O (173). It has recently been discovered that the E. coli and Salmonella type A flavoprotein flavorubredoxin represents another class of NO reductase (7, 98, 118). Flavorubredoxin contains a nonheme di-iron site that catalyzes the reduction of NO to N2O (49, 54). This dinuclear metal center is reminiscent of cytochrome c oxidase and cytochrome bo, but with iron instead of a copper as the nonheme metal (131, 158). In E. coli, NorR is a positive regulator of the flavorubredoxin encoded by the flrd gene, whereas Fnr downregulates its expression. In contrast to Hmp, expression of flavorubredoxin occurs preferentially under anaerobic conditions (29, 50). The role of flavorubredoxin in pathogenesis awaits investigation, although flavorubredoxin has been shown to protect the Krebs cycle aconitase and the Entner–Doudoroff pathway 6-phosphogluconate dehydrogenase from NO-related cytotoxicity (50).
Detoxification of Peroxynitrite.
Small molecules containing thiol groups provide a potent means to remove radicals. Two endogenous thiol-containing compounds that antagonize nitrosative stress have been identified in enteric bacteria. Homocysteine is an intermediate of the biosynthesis of methionine that has been associated with Salmonella virulence and resistance to an assortment of S-nitrosothiols (32). In addition, the tripeptide glutathione has been shown to reduce E. coli nitrosative stress, possibly by serving as a transnitrosation sink (62).
ROS and RNS produced by phagocytes in response to infection can oxidize purines and pyrimidines. The endonucleases Xth and Nfo protect Salmonella against the cytotoxicity of the NADPH oxidase and iNOS expressed by macrophages, and by doing so these enzymes increase Salmonella virulence in a murine experimental model (146). Evidently Salmonella base-excision DNA-repair systems repair oxidative damage produced by macrophage-derived ROS and RNS.
The extreme acidity of the stomach poses an insurmountable barrier for most microorganisms. However, enteropathogenic bacteria are innately capable of resisting the low gastric pH for short periods and can further adapt to this harsh environment by mounting an acid tolerance response. In addition to its direct antimicrobial activity, gastric acidity promotes the generation of a battery of toxic RNS. Dietary nitrate is an important source of nitrogen oxides in the alimentary tract. Nitrate ingested in food and water undergoes enterosalivary circulation, whereby it is estimated that about 25% of the dietary nitrate is secreted in saliva back into the mouth (reviewed in reference 99). Salivary nitrate is reduced to nitrite by facultative anaerobes such as Staphylococcus sciuri and S. intermedius populating the dorsal surface of the tongue (37). Nitrite is protonated in the acidic environment of the stomach, decomposing spontaneously to generate various nitrogen oxides such as NO, N2O3, NO2•, and S-nitrosothiols. It is estimated that chemical reactions in the upper intestine produce about 10,000 times the amount generated in tissues by enzymatic synthesis (100). The capacity of enteric bacteria to resist RNS is inversely correlated with their infective oral dose. For example, resistance of S. enteritidis to acidified nitrite is correlated with increased virulence of the microorganism via the oral route (88).
In addition to the chemical generation of nitrogen oxides from dietary nitrates, NO can be synthesized in the gastrointestinal mucosa in situ in response to enteropathogenic bacteria. This was first evidenced by elevated urinary NOx in humans with gastrointestinal infection (38, 123), and subsequently reaffirmed when elevated NO levels were found in the rectal lumen and plasma of patients with gastroenteritis (64). Colonic and ileal epithelial cells can express iNOS in response to invasive Shigella dysenteriae, S. flexneri, and S. enteritidis (15, 53, 71). Infection of human colon epithelial cells in vitro with the enteropathogens E. coli, Salmonella, or Shigella suggests that activation of iNOS and NO synthesis requires cell invasion (39, 169). However, this view has been challenged in a mouse model of enteropathogenic E. coli (EPEC) infection, in which expression of iNOS is induced in colonic epithelial cells in response to noninvasive Citrobacter rodentium (157). A paradigm in which signaling pathways initiated by effector proteins inoculated into the cytosol via type III secretion systems synergize with signals engendered through binding of pattern recognition receptors with cognate microbial molecules is gradually emerging to explain the activation of iNOS expression in enterocytes in response to enteropathogenic bacteria (20, 22, 39, 104, 105, 157).
Intestinal lamina propria dendritic cells can sample the intestinal lumen in an M-cell-independent manner and are capable of migrating to draining mesenteric lymph nodes and systemic circulation (125, 160). These dendritic cells therefore have the potential to extraintestinally disseminate pathogenic microorganisms that are capable of surviving in the intracellular environment of professional phagocytes (94, 160). Dendritic cells must be endowed with potent antimicrobial defenses to reduce the likelihood of their exploitation by microbes, and these defenses include iNOS (8, 43, 73, 136). NO produced by murine dendritic cells appears to exert bactericidal activity against Salmonella, whereas NO produced by macrophages is primarily bacteriostatic (43, 161).
Vodovotz et al. have reported that about 50% of cytosolic iNOS is loaded onto vesicles after posttranslational modifications facilitate partitioning of the hemoprotein into lipid membranes (164). This may have important implications for the antimicrobial activity associated with this enzymatic complex, since docking of iNOS-containing vesicles to the phagosomal membrane could allows host cells to deliver high NO fluxes to intraphagosomal bacteria. Analogous to its interactions with lysosomes and NADPH oxidase-containing vesicles, the Salmonella SPI2 type III secretion system thwarts trafficking of iNOS-harboring vacuoles (16). This activity limits Salmonella exposure to RNS and therefore increases Salmonella's prospect for survival. However, some populations of macrophages that are unable to mobilize iNOS from the vicinity of the plasma membrane to the Salmonella phagosome still possess NO-dependent anti-Salmonella activity (166), indicating that the intracellular localization of iNOS is not as critical for RNS to exert antimicrobial activity as for NADPH oxidase-derived ROS (163), presumably because NO is freely diffusible.
NO produced endogenously by iNOS exerts a variety of effects in the complex pathophysiology of enteric infections. The antimicrobial activity associated with different RNS directly contributes to the elimination of enteropathogens. NO can exert beneficial effects on host cells by regulating immune responses (40, 91) and by acting as a cytoprotectant (168), but NO overproduction can also be detrimental by promoting bacterial cell invasion, dissemination, and tissue damage.
Circumstantial evidence suggests that dietary nitrates and nitrites play important roles in gastric host defenses (90). In addition, experimental evidence strongly implicates endogenously produced NO in resistance to pathogens at the mucosal surface. For example, the high NO output of iNOS plays a role in resistance to oral salmonellosis. This has been nicely demonstrated by the observation that iNOS-deficient mice infected orally with Salmonella carry greater bacterial loads, suffer increased liver damage and hepatocellular apoptosis, and have higher septicemia and mortality rates than wild-type controls (2). Salmonella-infected iNOS-deficient mice exhibit increased hepatocellular apoptosis, while iNOS-related apoptosis is observed in renal epithelial cells exposed to uropathogenic E. coli (18) or Peyer's patches isolated from mice infected with S. enteritidis (15). Notably apoptosis in the latter case is correlated with the development of protective immunity.
Expression of iNOS is important in maintaining the homeostasis of the intestinal mucosa and, as described above, in protection against enteropathogenic bacteria. However, the overproduction of iNOS-derived NO has been implicated in a variety of intestinal disorders (22, 53, 97, 126). Overexpression of iNOS in response to S. enteritidis can inflict collateral damage to the intestinal epithelium (53), and high NO output stimulates guanylyl cyclase-mediated cGMP production that in turn causes hypersecretion and diarrhea (22). Coexpression of prostaglandin E2-producing COX2 can compound the negative effects of NO on chloride secretion and barrier function (22, 126). Therefore, NO can contribute along with other factors to diarrhea associated with enteropathogenic bacteria. In addition, iNOS has been associated with loss of the intestinal barrier and consequent increased bacterial translocation (69, 103), although the possibility also exists that NO decreases bacterial entry by stimulating mucus and fluid secretion (9).
Increased nitrite in plasma and iNOS mRNA can be detected as early as three days after infection, concomitantly with increased NO-DETC-Fe2+ ESR signals (2, 155). The expression of iNOS results in increased resistance to systemic Salmonella infections (96), as demonstrated by the fact that iNOS-deficient mice have a 1,000-fold reduction in LD50 compared with wild-type controls (2). Studies with mice carrying defined immunodeficiencies in iNOS are consistent with studies using pharmacological inhibitors of NO synthesis (32, 91, 155). However, high NO production does not necessarily correlate with enhanced resistance if other components of host defense such as macrophage migration inhibitory factor are lacking (79).
As described for mucosal immunity, NO can also be associated with pathological effects in certain systemic infections. NO may play a role in enhancing blood–brain-barrier permeability (13), and NO derived from nNOS, but not iNOS, seems to mediate inflammatory injury in a model of E. coli neonatal meningitis (117). In general, attempts to therapeutically block NO production have not improved the outcome of septic shock, although iNOS-immunodeficient mice are hyperresistant to LPS-induced endotoxemia (93). These studies suggest that the hypotension associated with LPS-induced septic shock principally results from massive production of NO by the iNOS isoform (6). Overall, these studies call for evaluation of inhibitors selective for individual NOS isoforms in the treatment of specific pathological conditions.
References
1. Ables, G. P., D. Takamatsu, H. Noma, S. El-Shazly, H. K. Jin, T. Taniguchi, K. Sekikawa, and T. Watanabe. 2001. The roles of Nramp1 and Tnfa genes in nitric oxide production and their effect on the growth of Salmonella typhimurium in macrophages from Nramp1 congenic and tumor necrosis factor-alpha-/- mice. J. Interferon Cytokine Res. 21:53–62.[PubMed] [CrossRef]
2. Alam, M. S., T. Akaike, S. Okamoto, T. Kubota, J. Yoshitake, T. Sawa, Y. Miyamoto, F. Tamura, and H. Maeda. 2002. Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect. Immun. 70:3130–3142.[PubMed] [CrossRef]
3. Albina, J. E. 1995. On the expression of nitric oxide synthase by human macrophages. Why no NO? J. Leukoc. Biol. 58:643–649.[PubMed]
4. Asai, Y., Y. Ohyama, K. Gen, and T. Ogawa. 2001. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect. Immun. 69:7387–7395.[PubMed] [CrossRef]
5. Balter-Seri, J., Y. Yuhas, A. Weizman, Y. Nofech-Mozes, E. Kaminsky, and S. Ashkenazi. 1999. Role of nitric oxide in the enhancement of pentylenetetrazole-induced seizures caused by Shigella dysenteriae. Infect. Immun. 67:6364–6368.[PubMed]
6. Bateman, R. M., M. D. Sharpe, and C. G. Ellis. 2003. Bench-to-bedside review: microvascular dysfunction in sepsis—hemodynamics, oxygen transport, and nitric oxide. Crit. Care 7:359–373.[PubMed] [CrossRef]
7. Blattner, F. R., G. Plunkett III, C. A. Bloch, N. T. Perna, V. Burland, M. Riley, J. Collado-Vides, J. D. Glasner, C. K. Rode, G. F. Mayhew, J. Gregor, N. W. Davis, H. A. Kirkpatrick, M. A. Goeden, D. J. Rose, B. Mau, and Y. Shao. 1997. The complete genome sequence of Escherichia coli K-12. Science 277:1453–1474.[PubMed] [CrossRef]
8. Bogdan, C. 2000. The function of type I interferons in antimicrobial immunity. Curr. Opin. Immunol. 12:419–424.[PubMed] [CrossRef]
9. Branka, J. E., G. Vallette, A. Jarry, and C. L. Laboisse. 1997. Stimulation of mucin exocytosis from human epithelial cells by nitric oxide: evidence for a cGMP-dependent and a cGMP-independent pathway. Biochem. J. 323(Pt 2):521–524.[PubMed]
10. Brunelli, L., J. P. Crow, and J. S. Beckman. 1995. The comparitive toxicity of nitric oxide and peroxynitrite to Escherichia coli. Arch. Biochem. Biophys. 316:327–334.[PubMed] [CrossRef]
11. Brunelli, L., V. Yermilov, and J. S. Beckman. 2001. Modulation of catalase peroxidatic and catalatic activity by nitric oxide. Free Radic. Biol. Med. 30:709–714.[PubMed] [CrossRef]
12. Bryk, R., P. Griffin, and C. Nathan. 2000. Peroxynitrite reductase activity of bacterial peroxiredoxins. Nature 407:211–215.[PubMed] [CrossRef]
13. Buster, B. L., A. C. Weintrob, G. C. Townsend, and W. M. Scheld. 1995. Potential role of nitric oxide in the pathophysiology of experimental bacterial meningitis in rats. Infect. Immun. 63:3835–3839.[PubMed]
14. Butler, C. S., H. E. Seward, C. Greenwood, and A. J. Thomson. 1997. Fast cytochrome bo from Escherichia coli binds two molecules of nitric oxide at CuB. Biochemistry 36:16259–16266.[PubMed] [CrossRef]
15. Cerquetti, M. C., N. B. Goren, A. J. Ropolo, D. Grasso, M. N. Giacomodonato, and M. I. Vaccaro. 2002. Nitric oxide and apoptosis induced in Peyer's patches by attenuated strains of Salmonella enterica serovar Enteritidis. Infect. Immun. 70:964–969.[PubMed] [CrossRef]
16. Chakravortty, D., I. Hansen-Wester, and M. Hensel. 2002. Salmonella pathogenicity island 2 mediates protection of intracellular Salmonella from reactive nitrogen intermediates. J. Exp. Med. 195:1155–1166.[PubMed] [CrossRef]
17. Chen, L., Q. W. Xie, and C. Nathan. 1998. Alkyl hydroperoxide reductase subunit C (AhpC) protects bacterial and human cells against reactive nitrogen intermediates. Mol. Cell 1:795–805.[PubMed] [CrossRef]
18. Chen, M., W. Bao, R. Aizman, P. Huang, O. Aspevall, L. E. Gustafsson, S. Ceccatelli, and G. Celsi. 2004. Activation of extracellular signal-regulated kinase mediates apoptosis induced by uropathogenic Escherichia coli toxins via nitric oxide synthase: protective role of heme oxygenase-1. J. Infect. Dis. 190:127–135.[PubMed] [CrossRef]
19. Cherayil, B. J., and D. Antos. 2001. Inducible nitric oxide synthase and Salmonella infection. Microb. Infect. 3:771–776. [CrossRef]
20. Cherayil, B. J., B. A. McCormick, and J. Bosley. 2000. Salmonella enterica serovar typhimurium-dependent regulation of inducible nitric oxide synthase expression in macrophages by invasins SipB, SipC, and SipD and effector SopE2. Infect. Immun. 68:5567–5574.[PubMed] [CrossRef]
21. Chu, S. C., J. Marks-Konczalik, H. P. Wu, T. C. Banks, and J. Moss. 1998. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem. Biophys. Res. Commun. 248:871–878.[PubMed] [CrossRef]
22. Closs, E. I., F. Enseleit, D. Koesling, J. M. Pfeilschifter, P. M. Schwarz, and U. Forstermann. 1998. Coexpression of inducible NO synthase and soluble guanylyl cyclase in colonic enterocytes: a pathophysiologic signaling pathway for the initiation of diarrhea by gram-negative bacteria? FASEB J. 12:1643–1649.[PubMed]
23. Cowley, S. C., S. V. Myltseva, and F. E. Nano. 1996. Phase variation in Francisella tularensis affecting intracellular growth, lipopolysaccharide antigenicity and nitric oxide production. Mol. Microbiol. 20:867–874.[PubMed] [CrossRef]
24. Crawford, M. J., and D. E. Goldberg. 1998. Regulation of the Salmonella typhimurium flavohemoglobin gene. A new pathway for bacterial gene expression in response to nitric oxide. J. Biol. Chem. 273:34028–34032.[PubMed] [CrossRef]
25. Crawford, M. J., and D. E. Goldberg. 1998. Role for the Salmonella flavohemoglobin in protection from nitric oxide. J. Biol. Chem. 273:12543–12547.[PubMed] [CrossRef]
26. Cruz-Ramos, H., J. Crack, G. Wu, M. N. Hughes, C. Scott, A. J. Thomson, J. Green, and R. K. Poole. 2002. NO sensing by FNR: regulation of the Escherichia coli NO-detoxifying flavohaemoglobin, Hmp. EMBO J. 21:3235–3244.[PubMed] [CrossRef]
27. D'Autreaux, B., O. Horner, J. L. Oddou, C. Jeandey, S. Gambarelli, C. Berthomieu, J. M. Latour, and I. Michaud-Soret. 2004. Spectroscopic description of the two nitrosyl-iron complexes responsible for fur inhibition by nitric oxide. J. Am. Chem. Soc. 126:6005–6016.[PubMed] [CrossRef]
28. D'Autreaux, B., D. Touati, B. Bersch, J. M. Latour, and I. Michaud-Soret. 2002. Direct inhibition by nitric oxide of the transcriptional ferric uptake regulation protein via nitrosylation of the iron. Proc. Natl. Acad. Sci. USA 99:16619–16624.[PubMed] [CrossRef]
29. da Costa, P. N., M. Teixeira, and L. M. Saraiva. 2003. Regulation of the flavorubredoxin nitric oxide reductase gene in Escherichia coli: nitrate repression, nitrite induction, and possible post-transcription control. FEMS Microbiol. Lett. 218:385–393.[PubMed] [CrossRef]
30. De Groote, M. A., D. Granger, Y. Xu, G. Campbell, R. Prince, and F. C. Fang. 1995. Genetic and redox determinants of nitric oxide cytotoxicity in a Salmonella typhimurium model. Proc. Natl. Acad. Sci. USA 92:6399–6403.[PubMed] [CrossRef]
31. De Groote, M. A., U. A. Ochsner, M. U. Shiloh, C. Nathan, J. M. McCord, M. C. Dinauer, S. J. Libby, A. Vazquez-Torres, Y. Xu, and F. C. Fang. 1997. Periplasmic superoxide dismutase protects Salmonella from products of phagocyte NADPH-oxidase and nitric oxide synthase. Proc. Natl. Acad. Sci. USA 94:13997–14001.[PubMed] [CrossRef]
32. De Groote, M. A., T. Testerman, Y. Xu, G. Stauffer, and F. C. Fang. 1996. Homocysteine antagonism of nitric oxide-related cytostasis in Salmonella typhimurium. Science 272:414–417.[PubMed] [CrossRef]
33. de Jong, R., F. Altare, I. A. Haagen, D. G. Elferink, T. Boer, P. J. van Breda Vriesman, P. J. Kabel, J. M. Draaisma, J. T. van Dissel, F. P. Kroon, J. L. Casanova, and T. H. Ottenhoff. 1998. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients. Science 280:1435–1438.[PubMed] [CrossRef]
34. DeGroote, M. A., and F. C. Fang. 1999. Antimicrobial Properties of Nitric Oxide. Kluwer Academic/Plenum Publishers, New York, N.Y.
35. Demple, B. 1996. Redox signaling and gene control in the Escherichia coli soxRS oxidative stress regulon—a review. Gene 179:53–57.[PubMed] [CrossRef]
36. Ding, H., and B. Demple. 2000. Direct nitric oxide signal transduction via nitrosylation of iron-sulfur centers in the SoxR transcription activator. Proc. Natl. Acad. Sci. USA 97:5146–5150.[PubMed] [CrossRef]
37. Duncan, C., H. Dougall, P. Johnston, S. Green, R. Brogan, C. Leifert, L. Smith, M. Golden, and N. Benjamin. 1995. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat. Med. 1:546–551.[PubMed] [CrossRef]
38. Dykhuizen, R. S., R. Frazer, C. Duncan, C. C. Smith, M. Golden, N. Benjamin, and C. Leifert. 1996. Antimicrobial effect of acidified nitrite on gut pathogens: importance of dietary nitrate in host defense. Antimicrob. Agents Chemother. 40:1422–1425.[PubMed]
39. Eaves-Pyles, T., K. Murthy, L. Liaudet, L. Virag, G. Ross, F. G. Soriano, C. Szabo, and A. L. Salzman. 2001. Flagellin, a novel mediator of Salmonella-induced epithelial activation and systemic inflammation: I kappa B alpha degradation, induction of nitric oxide synthase, induction of proinflammatory mediators, and cardiovascular dysfunction. J. Immunol. 166:1248–1260.[PubMed]
40. Ehrt, S., D. Schnappinger, S. Bekiranov, J. Drenkow, S. Shi, T. R. Gingeras, T. Gaasterland, G. Schoolnik, and C. Nathan. 2001. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J. Exp. Med. 194:1123–1140.[PubMed] [CrossRef]
41. Eiserich, J. P., M. Hristova, C. E. Cross, A. D. Jones, B. A. Freeman, B. Halliwell, and A. van der Vliet. 1998. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 391:393–397.[PubMed] [CrossRef]
42. Eriksson, S., J. Bjorkman, S. Borg, A. Syk, S. Pettersson, D. I. Andersson, and M. Rhen. 2000. Salmonella typhimurium mutants that downregulate phagocyte nitric oxide production. Cell. Microbiol. 2:239–250.[PubMed] [CrossRef]
43. Eriksson, S., B. J. Chambers, and M. Rhen. 2003. Nitric oxide produced by murine dendritic cells is cytotoxic for intracellular Salmonella enterica sv. Typhimurium. Scand. J. Immunol. 58:493–502.[PubMed] [CrossRef]
44. Everest, P., M. Roberts, and G. Dougan. 1998. Susceptibility to Salmonella typhimurium infection and effectiveness of vaccination in mice deficient in the tumor necrosis factor alpha p55 receptor. Infect. Immun. 66:3355–3364.[PubMed]
45. Fang, F. C. 2004. Antimicrobial reactive oxygen and nitrogen species: concepts and controversies. Nat. Rev. Microbiol. 2:820–832.[PubMed] [CrossRef]
46. Folcarelli, S., A. Battistoni, M. Falconi, P. O'Neill, G. Rotilio, and A. Desideri. 1998. Conserved enzyme-substrate electrostatic attraction in prokaryotic Cu,Zn superoxide dismutases. Biochem. Biophys. Res. Commun. 244:908–911.[PubMed] [CrossRef]
47. Fritsche, G., M. Dlaska, H. Barton, I. Theurl, K. Garimorth, and G. Weiss. 2003. Nramp1 functionality increases inducible nitric oxide synthase transcription via stimulation of IFN regulatory factor 1 expression. J. Immunol. 171:1994–1998.[PubMed]
48. Gallois, A., J. R. Klein, L. A. Allen, B. D. Jones, and W. M. Nauseef. 2001. Salmonella pathogenicity island 2-encoded type III secretion system mediates exclusion of NADPH oxidase assembly from the phagosomal membrane. J. Immunol. 166:5741–5748.[PubMed]
49. Gardner, A. M., and P. R. Gardner. 2002. Flavohemoglobin detoxifies nitric oxide in aerobic, but not anaerobic, Escherichia coli. Evidence for a novel inducible anaerobic nitric oxide-scavenging activity. J. Biol. Chem. 277:8166–8171.[PubMed] [CrossRef]
50. Gardner, A. M., R. A. Helmick, and P. R. Gardner. 2002. Flavorubredoxin, an inducible catalyst for nitric oxide reduction and detoxification in Escherichia coli. J. Biol. Chem. 277:8172–8177.[PubMed] [CrossRef]
51. Gardner, P. R., G. Costantino, C. Szabo, and A. L. Salzman. 1997. Nitric oxide sensitivity of the aconitases. J. Biol. Chem. 272:25071–25076.[PubMed] [CrossRef]
52. Gardner, P. R., A. M. Gardner, L. A. Martin, and A. L. Salzman. 1998. Nitric oxide dioxygenase: an enzymic function for flavohemoglobin. Proc. Natl. Acad. Sci. USA 95:10378–10383.[PubMed] [CrossRef]
53. Giacomodonato, M. N., N. B. Goren, D. O. Sordelli, M. I. Vaccaro, D. H. Grasso, A. J. Ropolo, and M. C. Cerquetti. 2003. Involvement of intestinal inducible nitric oxide synthase (iNOS) in the early stages of murine salmonellosis. FEMS Microbiol. Lett. 223:231–238.[PubMed] [CrossRef]
54. Gomes, C. M., A. Giuffre, E. Forte, J. B. Vicente, L. M. Saraiva, M. Brunori, and M. Teixeira. 2002. A novel type of nitric-oxide reductase. Escherichia coli flavorubredoxin. J. Biol. Chem. 277:25273–25276.[PubMed] [CrossRef]
55. Govoni, G., and P. Gros. 1998. Macrophage NRAMP1 and its role in resistance to microbial infections. Inflamm. Res. 47:277–284.[PubMed] [CrossRef]
56. Govoni, G., S. Vidal, M. Cellier, P. Lepage, D. Malo, and P. Gros. 1995. Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages. Genomics 27:9–19.[PubMed] [CrossRef]
57. Haskin, C. J., N. Ravi, J. B. Lynch, E. Munck, and L. Que, Jr. 1995. Reaction of NO with the reduced R2 protein of ribonucleotide reductase from Escherichia coli. Biochemistry 34:11090–11098.[PubMed] [CrossRef]
58. Hata-Tanaka, A., K. Matsuura, S. Itoh, and Y. Anraku. 1987. Electron flow and heme-heme interaction between cytochromes b-558, b-595 and d in a terminal oxidase of Escherichia coli. Biochim. Biophys. Acta 893:289–295.[PubMed] [CrossRef]
59. Hausladen, A., and I. Fridovich. 1994. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 269:29405–29408.[PubMed]
60. Hausladen, A., A. Gow, and J. S. Stamler. 2001. Flavohemoglobin denitrosylase catalyzes the reaction of a nitroxyl equivalent with molecular oxygen. Proc. Natl. Acad. Sci. USA 98:10108–10112.[PubMed] [CrossRef]
61. Hausladen, A., A. J. Gow, and J. S. Stamler. 1998. Nitrosative stress: metabolic pathway involving the flavohemoglobin. Proc. Natl. Acad. Sci. USA 95:14100–14105.[PubMed] [CrossRef]
62. Hausladen, A., C. T. Privalle, T. Keng, J. DeAngelo, and J. S. Stamler. 1996. Nitrosative stress: activation of the transcription factor OxyR. Cell 86:719–729.[PubMed] [CrossRef]
63. Hernandez-Urzua, E., C. E. Mills, G. P. White, M. L. Contreras-Zentella, E. Escamilla, S. G. Vasudevan, J. Membrillo-Hernandez, and R. K. Poole. 2003. Flavohemoglobin Hmp, but not its individual domains, confers protection from respiratory inhibition by nitric oxide in Escherichia coli. J. Biol. Chem. 278:34975–34982.[PubMed] [CrossRef]
64. Herulf, M., B. Svenungsson, A. Lagergren, T. Ljung, E. Morcos, N. P. Wiklund, J. O. Lundberg, and E. Weitzberg. 1999. Increased nitric oxide in infective gastroenteritis. J. Infect. Dis. 180:542–545.[PubMed] [CrossRef]
65. Hibbs, J. B., Jr., R. R. Taintor, Z. Vavrin, and E. M. Rachlin. 1988. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157:87–94.[PubMed] [CrossRef]
66. Hogg, N., R. J. Singh, E. Konorev, J. Joseph, and B. Kalyanaraman. 1997. S-Nitrosoglutathione as a substrate for gamma-glutamyl transpeptidase. Biochem. J. 323(Pt 2):477–481.[PubMed]
67. Hori, H., M. Tsubaki, T. Mogi, and Y. Anraku. 1996. EPR study of NO complex of bd-type ubiquinol oxidase from Escherichia coli. J. Biol. Chem. 271:9254–9258.[PubMed] [CrossRef]
68. Hou, Y., Z. Guo, J. Li, and P. G. Wang. 1996. Seleno compounds and glutathione peroxidase catalyzed decomposition of S-nitrosothiols. Biochem. Biophys. Res. Commun. 228:88–93.[PubMed] [CrossRef]
69. Inaba, T., J. W. Alexander, J. D. Ogle, and C. K. Ogle. 1999. Nitric oxide promotes the internalization and passage of viable bacteria through cultured Caco-2 intestinal epithelial cells. Shock 11:276–282.[PubMed] [CrossRef]
70. Ischiropoulos, H. 2003. Oxidative modifications of alpha-synuclein. Ann. N. Y. Acad. Sci. 991:93–100.[PubMed]
71. Islam, D., B. Veress, P. K. Bardhan, A. A. Lindberg, and B. Christensson. 1997. In situ characterization of inflammatory responses in the rectal mucosae of patients with shigellosis. Infect. Immun. 65:739–749.[PubMed]
72. Jensen, D. E., G. K. Belka, and G. C. Du Bois. 1998. S-Nitrosoglutathione is a substrate for rat alcohol dehydrogenase class III isoenzyme. Biochem. J. 331(Pt 2):659–668.[PubMed]
73. Kalupahana, R., A. R. Emilianus, D. Maskell, and B. Blacklaws. 2003. Salmonella enterica serovar Typhimurium expressing mutant lipid A with decreased endotoxicity causes maturation of murine dendritic cells. Infect. Immun. 71:6132–6140.[PubMed] [CrossRef]
74. Kamijo, R., H. Harada, T. Matsuyama, M. Bosland, J. Gerecitano, D. Shapiro, J. Le, S. I. Koh, T. Kimura, S. J. Green, T.W. Mak, T. Taniguchi, and J. Vilcek. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612–1615.[PubMed] [CrossRef]
75. Keyer, K., and J. A. Imlay. 1997. Inactivation of dehydratase [4Fe-4S] clusters and disruption of iron homeostasis upon cell exposure to peroxynitrite. J. Biol. Chem. 272:27652–27659.[PubMed] [CrossRef]
76. Khan, S. A., P. J. Strijbos, P. Everest, D. Moss, R. Stratford, P. Mastroeni, J. Allen, S. Servos, I. G. Charles, G. Dougan, and D. J. Maskell. 2001. Early responses to Salmonella typhimurium infection in mice occur at focal lesions in infected organs. Microb. Pathog. 30:29–38.[PubMed] [CrossRef]
77. Khor, H. K., M. Fisher, and C. Schoneich. 2004. Potential role of methionine sulfoxide in the inactivation of the chaperone GroEL by hypochlorous acid (HOCl) and peroxynitrite (ONOO-). J. Biol. Chem. 279:19486–19493.[PubMed] [CrossRef]
78. Kim, S. O., Y. Orii, D. Lloyd, M. N. Hughes, and R. K. Poole. 1999. Anoxic function for the Escherichia coli flavohaemoglobin (Hmp): reversible binding of nitric oxide and reduction to nitrous oxide. FEBS Lett. 445:389–394.[PubMed] [CrossRef]
79. Koebernick, H., L. Grode, J. R. David, W. Rohde, M. S. Rolph, H. W. Mittrucker, and S. H. Kaufmann. 2002. Macrophage migration inhibitory factor (MIF) plays a pivotal role in immunity against Salmonella typhimurium. Proc. Natl. Acad. Sci. USA 99:13681–13686.[PubMed] [CrossRef]
80. Kolyada, A. Y., N. Savikovsky, and N. E. Madias. 1996. Transcriptional regulation of the human iNOS gene in vascular-smooth-muscle cells and macrophages: evidence for tissue specificity. Biochem. Biophys. Res. Commun. 220:600–605.[PubMed] [CrossRef]
81. Koppenol, W. H., J. J. Moreno, W. A. Pryor, H. Ischiropoulos, and J. S. Beckman. 1992. Peroxynitrite, a cloaked oxidant formed by nitric oxide and superoxide. Chem. Res. Toxicol. 5:834–842.[PubMed] [CrossRef]
82. Kroncke, K. D., and C. Carlberg. 2000. Inactivation of zinc finger transcription factors provides a mechanism for a gene regulatory role of nitric oxide. FASEB J. 14:166–173.[PubMed]
83. Kroncke, K. D., K. Fehsel, T. Schmidt, F. T. Zenke, I. Dasting, J. R. Wesener, H. Bettermann, K. D. Breunig, and V. Kolb-Bachofen. 1994. Nitric oxide destroys zinc-sulfur clusters inducing zinc release from metallothionein and inhibition of the zinc finger-type yeast transcription activator LAC9. Biochem. Biophys. Res. Commun. 200:1105–1110.[PubMed] [CrossRef]
84. Lepoivre, M., F. Fieschi, J. Coves, L. Thelander, and M. Fontecave. 1991. Inactivation of ribonucleotide reductase by nitric oxide. Biochem. Biophys. Res. Commun. 179:442–448.[PubMed] [CrossRef]
85. Levine, R. L., L. Mosoni, B. S. Berlett, and E. R. Stadtman. 1996. Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. USA 93:15036–15040.[PubMed] [CrossRef]
86. Liu, L., A. Hausladen, M. Zeng, L. Que, J. Heitman, and J. S. Stamler. 2001. A metabolic enzyme for S-nitrosothiol conserved from bacteria to humans. Nature 410:490–494.[PubMed] [CrossRef]
87. Lu, S., P. B. Killoran, F. C. Fang, and L. W. Riley. 2002. The global regulator ArcA controls resistance to reactive nitrogen and oxygen intermediates in Salmonella enterica serovar Enteritidis. Infect. Immun. 70:451–461.[PubMed] [CrossRef]
88. Lu, S., A. R. Manges, Y. Xu, F. C. Fang, and L. W. Riley. 1999. Analysis of virulence of clinical isolates of Salmonella enteritidis in vivo and in vitro. Infect. Immun. 67:5651–5657.[PubMed]
89. Lundberg, B. E., R. E. Wolf, Jr., M. C. Dinauer, Y. Xu, and F. C. Fang. 1999. Glucose 6-phosphate dehydrogenase is required for Salmonella typhimurium virulence and resistance to reactive oxygen and nitrogen intermediates. Infect. Immun. 67:436–438.[PubMed]
90. Lundberg, J. O., E. Weitzberg, J. A. Cole, and N. Benjamin. 2004. Nitrate, bacteria and human health. Nat. Rev. Microbiol. 2:593–602.[PubMed] [CrossRef]
91. MacFarlane, A. S., M. G. Schwacha, and T. K. Eisenstein. 1999. In vivo blockage of nitric oxide with aminoguanidine inhibits immunosuppression induced by an attenuated strain of Salmonella typhimurium, potentiates Salmonella infection, and inhibits macrophage and polymorphonuclear leukocyte influx into the spleen. Infect. Immun. 67:891–898.[PubMed]
92. MacMicking, J., Q. W. Xie, and C. Nathan. 1997. Nitric oxide and macrophage function. Annu. Rev. Immunol. 15:323–350.[PubMed] [CrossRef]
93. MacMicking, J. D., C. Nathan, G. Hom, N. Chartrain, D. S. Fletcher, M. Trumbauer, K. Stevens, Q. W. Xie, K. Sokol, N. Hutchinson, H. Chen, and J. S. Mudgett. 1995. Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 81:641–650.[PubMed] [CrossRef]
94. Macpherson, A. J., and T. Uhr. 2004. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 303:1662–1665.[PubMed] [CrossRef]
95. Marcatili, A., M. D'Isanto, M. Galdiero, U. Pagnini, E. Palomba, M. Vitiello, and F. Martone. 2000. Role of Pasteurella multocida, Pasteurella haemolytica and Salmonella typhimurium porins on inducible nitric oxide release by murine macrophages. Res. Microbiol. 151:217–228.[PubMed] [CrossRef]
96. Mastroeni, P., A. Vazquez-Torres, F. C. Fang, Y. Xu, S. Khan, C. E. Hormaeche, and G. Dougan. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. II. Effects on microbial proliferation and host survival in vivo. J. Exp. Med. 192:237–248.[PubMed] [CrossRef]
97. McCafferty, D. M., E. Sihota, M. Muscara, J. L. Wallace, K. A. Sharkey, and P. Kubes. 2000. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am. J. Physiol. 279:G90–G99.
98. McClelland, M., K. E. Sanderson, J. Spieth, S. W. Clifton, P. Latreille, L. Courtney, S. Porwollik, J. Ali, M. Dante, F. Du, S. Hou, D. Layman, S. Leonard, C. Nguyen, K. Scott, A. Holmes, N. Grewal, E. Mulvaney, E. Ryan, H. Sun, L. Florea, W. Miller, T. Stoneking, M. Nhan, R. Waterston, and R. K. Wilson. 2001. Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature 413:852–856.[PubMed] [CrossRef]
99. McKnight, G. M., C. W. Duncan, C. Leifert, and M. H. Golden. 1999. Dietary nitrate in man: friend or foe? Br. J. Nutr. 81:349–358.[PubMed]
100. McKnight, G. M., L. M. Smith, R. S. Drummond, C. W. Duncan, M. Golden, and N. Benjamin. 1997. Chemical synthesis of nitric oxide in the stomach from dietary nitrate in humans. Gut 40:211–214.[PubMed]
101. Membrillo-Hernandez, J., M. D. Coopamah, M. F. Anjum, T. M. Stevanin, A. Kelly, M. N. Hughes, and R. K. Poole. 1999. The flavohemoglobin of Escherichia coli confers resistance to a nitrosating agent, a "Nitric oxide Releaser," and paraquat and is essential for transcriptional responses to oxidative stress. J. Biol. Chem. 274:748–754.[PubMed] [CrossRef]
102. Membrillo-Hernandez, J., M. D. Coopamah, A. Channa, M. N. Hughes, and R. K. Poole. 1998. A novel mechanism for upregulation of the Escherichia coli K-12 hmp (flavohaemoglobin) gene by the 'NO releaser', S-nitrosoglutathione: nitrosation of homocysteine and modulation of MetR binding to the glyA-hmp intergenic region. Mol. Microbiol. 29:1101–1112.[PubMed] [CrossRef]
103. Mishima, S., D. Xu, Q. Lu, and E. A. Deitch. 1997. Bacterial translocation is inhibited in inducible nitric oxide synthase knockout mice after endotoxin challenge but not in a model of bacterial overgrowth. Arch. Surg. 132:1190–1195.[PubMed]
104. Mizel, S. B., A. N. Honko, M. A. Moors, P. S. Smith, and A. P. West. 2003. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. J. Immunol. 170:6217–6223.[PubMed]
105. Moors, M. A., L. Li, and S. B. Mizel. 2001. Activation of interleukin-1 receptor-associated kinase by gram-negative flagellin. Infect. Immun. 69:4424–4429.[PubMed] [CrossRef]
106. Mukhopadhyay, P., M. Zheng, L. A. Bedzyk, R. A. LaRossa, and G. Storz. 2004. Prominent roles of the NorR and Fur regulators in the Escherichia coli transcriptional response to reactive nitrogen species. Proc. Natl. Acad. Sci. USA 101:745–750.[PubMed] [CrossRef]
107. Muroi, M., and K. Tanamoto. 2002. The polysaccharide portion plays an indispensable role in Salmonella lipopolysaccharide-induced activation of NF-kappaB through human toll-like receptor 4. Infect. Immun. 70:6043–6047.[PubMed] [CrossRef]
108. Nathan, C., and M. U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97:8841–8848.[PubMed] [CrossRef]
109. Nathan, C., and Q. W. Xie. 1994. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915–918.[PubMed] [CrossRef]
110. Nikitovic, D., and A. Holmgren. 1996. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide. J. Biol. Chem. 271:19180–19185.[PubMed] [CrossRef]
111. Nowicki, B., J. Singhal, L. Fang, S. Nowicki, and C. Yallampalli. 1999. Inverse relationship between severity of experimental pyelonephritis and nitric oxide production in C3H/HeJ mice. Infect. Immun. 67:2421–2427.[PubMed]
112. Nunokawa, Y., N. Ishida, and S. Tanaka. 1994. Promoter analysis of human inducible nitric oxide synthase gene associated with cardiovascular homeostasis. Biochem. Biophys. Res. Commun. 200:802–807.[PubMed] [CrossRef]
113. Nunoshiba, T., T. DeRojas-Walker, S. R. Tannenbaum, and B. Demple. 1995. Roles of nitric oxide in inducible resistance of Escherichia coli to activated murine macrophages. Infect. Immun. 63:794–798.[PubMed]
114. Nunoshiba, T., T. deRojas-Walker, J. S. Wishnok, S. R. Tannenbaum, and B. Demple. 1993. Activation by nitric oxide of an oxidative-stress response that defends Escherichia coli against activated macrophages. Proc. Natl. Acad. Sci. USA 90:9993–9997.[PubMed] [CrossRef]
115. Nurse, P., K. H. Zavitz, and K. J. Marians. 1991. Inactivation of the Escherichia coli priA DNA replication protein induces the SOS response. J. Bacteriol. 173:6686–6693.[PubMed]
116. Pacelli, R., D. A. Wink, J. A. Cook, M. C. Krishna, W. DeGraff, N. Friedman, M. Tsokos, A. Samuni, and J. B. Mitchell. 1995. Nitric oxide potentiates hydrogen peroxide-induced killing of Escherichia coli. J. Exp. Med. 182:1469–1479.[PubMed] [CrossRef]
117. Park, W. S., Y. S. Chang, and M. Lee. 2001. 7-Nitroindazole, but not aminoguanidine, attenuates the acute inflammatory responses and brain injury during the early phase of Escherichia coli meningitis in the newborn piglet. Biol. Neonate 80:53–59.[PubMed] [CrossRef]
118. Parkhill, J., G. Dougan, K. D. James, N. R. Thomson, D. Pickard, J. Wain, C. Churcher, K. L. Mungall, S. D. Bentley, M. T. Holden, M. Sebaihia, S. Baker, D. Basham, K. Brooks, T. Chillingworth, P. Connerton, A. Cronin, P. Davis, R. M. Davies, L. Dowd, N. White, J. Farrar, T. Feltwell, N. Hamlin, A. Haque, T. T. Hien, S. Holroyd, K. Jagels, A. Krogh, T. S. Larsen, S. Leather, S. Moule, P. O'Gaora, C. Parry, M. Quail, K. Rutherford, M. Simmonds, J. Skelton, K. Stevens, S. Whitehead, and B. G. Barrell. 2001. Complete genome sequence of a multiple drug resistant Salmonella enterica serovar Typhi CT18. Nature 413:848–852.[PubMed] [CrossRef]
119. Poljakovic, M., and K. Persson. 2003. Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide. Am. J. Physiol. 284:F22–F31.
120. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088.[PubMed] [CrossRef]
121. Poole, R. K., M. F. Anjum, J. Membrillo-Hernandez, S. O. Kim, M. N. Hughes, and V. Stewart. 1996. Nitric oxide, nitrite, and Fnr regulation of hmp (flavohemoglobin) gene expression in Escherichia coli K-12. J. Bacteriol. 178:5487–5492.[PubMed]
122. Pryor, W. A., and G. L. Squadrito. 1995. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am. J. Physiol. 268:L699–L722.[PubMed]
123. Rabbani, G. H., S. Islam, A. K. Chowdhury, A. K. Mitra, M. J. Miller, and G. Fuchs. 2001. Increased nitrite and nitrate concentrations in sera and urine of patients with cholera or shigellosis. Am. J. Gastroenterol. 96:467–472.[PubMed] [CrossRef]
124. Radi, R. 2004. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 101:4003–4008.[PubMed] [CrossRef]
125. Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. 2001. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2:361–367.[PubMed] [CrossRef]
126. Resta-Lenert, S., and K. E. Barrett. 2002. Enteroinvasive bacteria alter barrier and transport properties of human intestinal epithelium: role of iNOS and COX-2. Gastroenterology 122:1070–1087.[PubMed] [CrossRef]
127. Rosenberger, C. M., M. G. Scott, M. R. Gold, R. E. Hancock, and B. B. Finlay. 2000. Salmonella typhimurium infection and lipopolysaccharide stimulation induce similar changes in macrophage gene expression. J. Immunol. 164:5894–5904.[PubMed]
128. Royle, M. C., S. Totemeyer, L. C. Alldridge, D. J. Maskell, and C. E. Bryant. 2003. Stimulation of Toll-like receptor 4 by lipopolysaccharide during cellular invasion by live Salmonella typhimurium is a critical but not exclusive event leading to macrophage responses. J. Immunol. 170:5445–5454.[PubMed]
129. Saito, S., K. Onozuka, H. Shinomiya, and M. Nakano. 1991. Sensitivity of bacteria to NaNO2 and to L-arginine-dependent system in murine macrophages. Microbiol. Immunol. 35:325–329.[PubMed]
130. Sansone, A., P. R. Watson, T. S. Wallis, P. R. Langford, and J. S. Kroll. 2002. The role of two periplasmic copper- and zinc-cofactored superoxide dismutases in the virulence of Salmonella choleraesuis. Microbiology 148:719–726.[PubMed]
131. Saraste, M., and J. Castresana. 1994. Cytochrome oxidase evolved by tinkering with denitrification enzymes. FEBS Lett. 341:1–4.[PubMed] [CrossRef]
132. Schapiro, J. M., S. J. Libby, and F. C. Fang. 2003. Inhibition of bacterial DNA replication by zinc mobilization during nitrosative stress. Proc. Natl. Acad. Sci. USA 100:8496–8501.[PubMed] [CrossRef]
133. Schilling, D., K. Thomas, K. Nixdorff, S. N. Vogel, and M. J. Fenton. 2002. Toll-like receptor 4 and Toll-IL-1 receptor domain-containing adapter protein (TIRAP)/myeloid differentiation protein 88 adapter-like (Mal) contribute to maximal IL-6 expression in macrophages. J. Immunol. 169:5874–5880.[PubMed]
134. Schneemann, M., G. Schoedon, S. Hofer, N. Blau, L. Guerrero, and A. Schaffner. 1993. Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 167:1358–1363.[PubMed]
135. Scorza, G., D. Pietraforte, and M. Minetti. 1997. Role of ascorbate and protein thiols in the release of nitric oxide from S-nitroso-albumin and S-nitroso-glutathione in human plasma. Free Radic. Biol. Med. 22:633–642.[PubMed] [CrossRef]
136. Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59–70.[PubMed] [CrossRef]
137. Shiloh, M. U., J. D. MacMicking, S. Nicholson, J. E. Brause, S. Potter, M. Marino, F. Fang, M. Dinauer, and C. Nathan. 1999. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10:29–38.[PubMed] [CrossRef]
138. Singh, S. P., J. S. Wishnok, M. Keshive, W. M. Deen, and S. R. Tannenbaum. 1996. The chemistry of the S-nitrosoglutathione/glutathione system. Proc. Natl. Acad. Sci. USA 93:14428–14433.[PubMed] [CrossRef]
139. St John, G., N. Brot, J. Ruan, H. Erdjument-Bromage, P. Tempst, H. Weissbach, and C. Nathan. 2001. Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates. Proc. Natl. Acad. Sci. USA 98:9901–9906.[PubMed] [CrossRef]
140. Stevanin, T. M., N. Ioannidis, C. E. Mills, S. O. Kim, M. N. Hughes, and R. K. Poole. 2000. Flavohemoglobin Hmp affords inducible protection for Escherichia coli respiration, catalyzed by cytochromes bo' or bd, from nitric oxide. J. Biol. Chem. 275:35868–35875.[PubMed] [CrossRef]
141. Stevanin, T. M., R. K. Poole, E. A. Demoncheaux, and R. C. Read. 2002. Flavohemoglobin Hmp protects Salmonella enterica serovar Typhimurium from nitric oxide-related killing by human macrophages. Infect. Immun. 70:4399–4405.[PubMed] [CrossRef]
142. Stuehr, D. J. 1999. Mammalian nitric oxide synthases. Biochim. Biophys. Acta 1411:217–230.[PubMed] [CrossRef]
143. Stuehr, D. J., N. S. Kwon, C. F. Nathan, O. W. Griffith, P. L. Feldman, and J. Wiseman. 1991. N omega-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J. Biol. Chem. 266:6259–6263.[PubMed]
144. Stuehr, D. J., and M. A. Marletta. 1987. Induction of nitrite/nitrate synthesis in murine macrophages by BCG infection, lymphokines, or interferon-gamma. J. Immunol. 139:518–525.[PubMed]
145. Stuehr, D. J., and M. A. Marletta. 1985. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA 82:7738–7742.[PubMed] [CrossRef]
146. Suvarnapunya, A. E., H. A. Lagasse, and M. A. Stein. 2003. The role of DNA base excision repair in the pathogenesis of Salmonella enterica serovar Typhimurium. Mol. Microbiol. 48:549–559.[PubMed] [CrossRef]
147. Tanamoto, K., and S. Azumi. 2000. Salmonella-type heptaacylated lipid A is inactive and acts as an antagonist of lipopolysaccharide action on human line cells. J. Immunol. 164:3149–3156.[PubMed]
148. Tannenbaum, S. R. 1979. Nitrate and nitrite: origin in humans. Science 205:1332, 1334–1337.[PubMed]
149. Tannenbaum, S. R., D. Fett, V. R. Young, P. D. Land, and W. R. Bruce. 1978. Nitrite and nitrate are formed by endogenous synthesis in the human intestine. Science 200:1487–1489.[PubMed] [CrossRef]
150. Tapping, R. I., S. Akashi, K. Miyake, P. J. Godowski, and P. S. Tobias. 2000. Toll-like receptor 4, but not toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J. Immunol. 165:5780–5787.[PubMed]
151. Taylor, B. S., and D. A. Geller. 2000. Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock 13:413–424.[PubMed]
152. Taylor, P. D., C. J. Inchley, and M. P. Gallagher. 1998. The Salmonella typhimurium AhpC polypeptide is not essential for virulence in BALB/c mice but is recognized as an antigen during infection. Infect. Immun. 66:3208–3217.[PubMed]
153. Toshchakov, V., B. W. Jones, P. Y. Perera, K. Thomas, M. J. Cody, S. Zhang, B. R. Williams, J. Major, T. A. Hamilton, M. J. Fenton, and S. N. Vogel. 2002. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat. Immunol. 3:392–398.[PubMed] [CrossRef]
154. Trujillo, M., M. N. Alvarez, G. Peluffo, B. A. Freeman, and R. Radi. 1998. Xanthine oxidase-mediated decomposition of S-nitrosothiols. J. Biol. Chem. 273:7828–7834.[PubMed] [CrossRef]
155. Umezawa, K., T. Akaike, S. Fujii, M. Suga, K. Setoguchi, A. Ozawa, and H. Maeda. 1997. Induction of nitric oxide synthesis and xanthine oxidase and their roles in the antimicrobial mechanism against Salmonella typhimurium infection in mice. Infect. Immun. 65:2932–2940.[PubMed]
156. Utaisincharoen, P., N. Tangthawornchaikul, W. Kespichayawattana, N. Anuntagool, P. Chaisuriya, and S. Sirisinha. 2000. Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-alpha (TNF-alpha) in macrophages stimulated with Burkholderia pseudomallei endotoxin. Clin. Exp. Immunol. 122:324–329.[PubMed] [CrossRef]
157. Vallance, B. A., W. Deng, M. De Grado, C. Chan, K. Jacobson, and B. B. Finlay. 2002. Modulation of inducible nitric oxide synthase expression by the attaching and effacing bacterial pathogen Citrobacter rodentium in infected mice. Infect. Immun. 70:6424–6435.[PubMed] [CrossRef]
158. van der Oost, J., A. P. de Boer, J. W. de Gier, W. G. Zumft, A. H. Stouthamer, and R. J. van Spanning. 1994. The heme-copper oxidase family consists of three distinct types of terminal oxidases and is related to nitric oxide reductase. FEMS Microbiol. Lett. 121:1–9.[PubMed] [CrossRef]
159. Vazquez-Torres, A., G. Fantuzzi, C. K. Edwards III, C. A. Dinarello, and F. C. Fang. 2001. Defective localization of the NADPH phagocyte oxidase to Salmonella-containing phagosomes in tumor necrosis factor p55 receptor-deficient macrophages. Proc. Natl. Acad. Sci. USA 98:2561–2565.[PubMed] [CrossRef]
160. Vazquez-Torres, A., J. Jones-Carson, A. J. Baumler, S. Falkow, R. Valdivia, W. Brown, M. Le, R. Berggren, W. T. Parks, and F. C. Fang. 1999. Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401:804–808.[PubMed] [CrossRef]
161. Vazquez-Torres, A., J. Jones-Carson, P. Mastroeni, H. Ischiropoulos, and F. C. Fang. 2000. Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro. J. Exp. Med. 192:227–236.[PubMed] [CrossRef]
162. Vazquez-Torres, A., B. A. Vallance, M. A. Bergman, B. B. Finlay, B. T. Cookson, J. Jones-Carson, and F. C. Fang. 2004. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella: importance of the Kupffer cell network. J. Immunol. 172:6202–6208.[PubMed]
163. Vazquez-Torres, A., Y. Xu, J. Jones-Carson, D. W. Holden, S. M. Lucia, M. C. Dinauer, P. Mastroeni, and F. C. Fang. 2000. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science 287:1655–1658.[PubMed] [CrossRef]
164. Vodovotz, Y., D. Russell, Q. W. Xie, C. Bogdan, and C. Nathan. 1995. Vesicle membrane association of nitric oxide synthase in primary mouse macrophages. J. Immunol. 154:2914–2925.[PubMed]
165. Vogt, W. 1995. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic. Biol. Med. 18:93–105.[PubMed] [CrossRef]
166. Webb, J. L., M. W. Harvey, D. W. Holden, and T. J. Evans. 2001. Macrophage nitric oxide synthase associates with cortical actin but is not recruited to phagosomes. Infect. Immun. 69:6391–6400.[PubMed] [CrossRef]
167. Weinberg, J. B. 1998. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: a review. Mol. Med. 4:557–591.[PubMed]
168. Wink, D. A., Y. Vodovotz, M. B. Grisham, W. DeGraff, J. C. Cook, R. Pacelli, M. Krishna, and J. B. Mitchell. 1999. Antioxidant effects of nitric oxide. Methods Enzymol. 301:413–424.[PubMed] [CrossRef]
169. Witthoft, T., L. Eckmann, J. M. Kim, and M. F. Kagnoff. 1998. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am. J. Physiol. 275:G564–G571.[PubMed]
170. Woodmansee, A. N., and J. A. Imlay. 2003. A mechanism by which nitric oxide accelerates the rate of oxidative DNA damage in Escherichia coli. Mol. Microbiol. 49:11–22.[PubMed] [CrossRef]
171. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705–4708.[PubMed]
172. Zheng, M., F. Aslund, and G. Storz. 1998. Activation of the OxyR transcription factor by reversible disulfide bond formation. Science 279:1718–1721.[PubMed] [CrossRef]
173. Zumft, W. G. 1997. Cell biology and molecular basis of denitrification. Microbiol. Mol. Biol. Rev. 61:533–616.[PubMed]